default author photo

Ria Goswami

Duke University - Duke Human Vaccine Institute

United States

SCHOLARLY PAPERS

2

DOWNLOADS

71

TOTAL CITATIONS

3

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Maternal Broadly Neutralizing Antibodies Select for Neutralization-Resistant Infant Transmitted/Founder HIV Variants

Number of pages: 60 Posted: 06 May 2019
David R. Martinez, Amit Kumar, Joshua J. Tu, Jesse F. Mangold, Riley J. Mangan, Ria Goswami, Elena E. Giorgi, Juilin Chen, Michael Mengual, Ayooluwa O. Douglas, Holly Heimsath, Kevin Saunders, Nathan I. Nicely, Joshua Eudailey, Giovanna Hernandez, Papa Morgan-Asiedu, Kevin Wiehe, Celia LaBranche, David C. Montefiori, Feng Gao and Sallie Permar
Duke University - Department of Molecular Genetics and Microbiology, Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Government of the United States of America - Los Alamos National Laboratory, Duke Human Vaccine Institute, Duke University - Department of Medicine, Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Division of Surgical Sciences, Duke University - Department of Medicine and Duke University - Department of Molecular Genetics and Microbiology
Downloads 38 (1,222,651)
Citation 3

Abstract:

Loading...

bNAbs, infant T/F virus, mother-to-child-transmission, HIV, neutralization

2.

Oral Hsp90 Inhibitor, SNX-5422, Attenuates SARS-CoV-2 Replication and Dampens Inflammation in Airway Cells

Number of pages: 66 Posted: 12 Mar 2021
Ria Goswami, Veronica S. Russell, Joshua J. Tu, Philip F. Hughes, Francine Kelly, Stephanie N. Langel, Justin Steppe, Scott M. Palmer, Timothy Haystead, Maria Blasi and Sallie Permar
Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Division of Pulmonary, Allergy and Critical Care Medicine, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Division of Pulmonary, Allergy and Critical Care Medicine, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Duke Human Vaccine Institute and Duke University - Department of Molecular Genetics and Microbiology
Downloads 33 (1,277,121)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Hsp90, Post-exposure prophylaxis, anti-inflammatory, host directed therapy, orally bioavailable